Roger Connor, a member of GlaxoSmithKline Plc’s executive team since 2012, has been appointed president of vaccines, effective 1 September, following the decision by Luc Debruyne to leave the company at the end of the year. Mr Connor is currently president for global manufacturing and supply. In his new role as head of vaccines, he will be overseeing one of GSK’s three main divisions.
GSK announced the appointment on 12 June 2018.
Copyright 2018 Evernow Publishing Ltd